Package 77771-175-05

{"route": ["ORAL"], "spl_id": "5a38f43e-ac1b-4cf2-b454-79d08f5dd555", "openfda": {"upc": ["0377771175054", "0377771174057"], "unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["161637d2-bc9d-4a2b-ad1f-6cc39ffd69ce"], "manufacturer_name": ["Radha Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-175-05)", "package_ndc": "77771-175-05", "marketing_start_date": "20210415"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (77771-175-60)", "package_ndc": "77771-175-60", "marketing_start_date": "20210415"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "77771-175_5a38f43e-ac1b-4cf2-b454-79d08f5dd555", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "77771-175", "generic_name": "bupropion hydrochloride", "labeler_name": "Radha Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA205794", "marketing_category": "ANDA", "marketing_start_date": "20210415", "listing_expiration_date": "20271231"}